In the stratified analysis (Table 4 and Table 5), overexpression of RAD51B was prominently associated with the decreasing death risk of death for patients with squamous cell carcinoma (HR=0.68, 95%CI: 0.51∼0.90). The gene discussed is RAD51B; the disease is squamous cell carcinoma.